BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alfaro E, Díaz-garcía E, García-tovar S, Zamarrón E, Mangas A, Galera R, Nanwani-nanwani K, Pérez-de-diego R, López-collazo E, García-río F, Cubillos-zapata C. Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity. Front Immunol 2022;13:909342. [DOI: 10.3389/fimmu.2022.909342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 van de Sand L, Braß P, Gregorius J, Pattberg K, Engler A, Dittmer U, Taube C, Brock S, Berger MM, Brenner T, Witzke O, Krawczyk A. Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients. J Clin Med 2022;12. [PMID: 36615083 DOI: 10.3390/jcm12010283] [Reference Citation Analysis]
2 Mendes GMM, Do Nascimento IJB, Marazzi-Diniz PH, Da Silveira IB, Itaborahy MF, Viana LE, Silva FA, Santana MF, Pinto RA, Dutra BG, Lacerda MVG, Araujo SA, Wanderley D, Vidigal PV, Diniz PH, Verano-Braga T, Santos RA, Leite MF. The des-Arg(9)-bradykinin/B1R axis: Hepatic damage in COVID-19. Front Physiol 2022;13:1080837. [PMID: 36601349 DOI: 10.3389/fphys.2022.1080837] [Reference Citation Analysis]
3 Sun Y, Zou Y, Wang H, Cui G, Yu Z, Ren Z. Immune response induced by novel coronavirus infection. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.988604] [Reference Citation Analysis]
4 Urwyler P, Moser S, Trendelenburg M, Sendi P, Osthoff M. Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. Mol Immunol 2022;150:99-113. [PMID: 36030710 DOI: 10.1016/j.molimm.2022.08.008] [Reference Citation Analysis]